|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Loreal USA |
|---|---|
| Information provided by: | Loreal USA |
| ClinicalTrials.gov Identifier: | NCT00368563 |
Purpose
To evaluate the ability of 2 Helioblock SX Cream formulations to moisturize skin using capacitance and transepidermal water loss methodology
| Condition | Intervention | Phase |
|---|---|---|
|
Dry Skin |
Drug: Helioblock SX |
Phase II Phase III |
| Study Type: | Interventional |
| Study Design: | Randomized, Single Blind, Uncontrolled, Single Group Assignment |
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | PEN.1010.02 |
| Study First Received: | August 23, 2006 |
| Last Updated: | February 10, 2009 |
| ClinicalTrials.gov Identifier: | NCT00368563 History of Changes |
| Health Authority: | United States: Food and Drug Administration |